Patent · US Active

Process of making regadenoson and novel polymorph thereof

US10442832B2 · kind B2 · utility

0Cited by

12References

9Claims

0Family size

Assignee

Apicore US LLC · US

Inventors

Ravishanker Kovi · Sparta, US
Ashish Naik · Piscataway, US
Piyush Fadadu · Vadodara, IN
Jayaraman Kannapan · Sayla, IN

Key dates

Filing date	Feb 2, 2016
Grant date	Oct 15, 2019
Priority date	—
Expiry date	Jan 11, 2037

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07H19/167
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Novel processes for making the N-pyrrazole substituted 2-adenosine derivative regadenoson and a novel polymorph thereof. The novel polymorph of regadenoson designated form H and drug substances and pharmaceutical compositions including the novel polymorph H are disclosed.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.